✕ CLOSE Online Special City News Entrepreneurship Environment Factcheck Everything Woman Home Front Islamic Forum Life Xtra Property Travel & Leisure Viewpoint Vox Pop Women In Business Art and Ideas Bookshelf Labour Law Letters
Click Here To Listen To Trust Radio Live

AKTH collating data from new glaucoma treatment procedure

Aminu Kano Teaching Hospital (AKTH) has commenced collation of data from a new treatment procedure for Glaucoma, using a machine called Diode Laser to ascertain…

Aminu Kano Teaching Hospital (AKTH) has commenced collation of data from a new treatment procedure for Glaucoma, using a machine called Diode Laser to ascertain it’s effectiveness.

Dr Sadiq Hassan, a consultant Ophthalmologist at the hospital said this is one of the many researches taking place at the department.

According to him, the Diode laser treatment for Glaucoma started last year saying that we are presently taking data to see its effectiveness.

“It’s a relatively new method for treating people with Glaucoma. Glaucoma is number two cause of blindness worldwide and number one cause of irreversible blindness ” he added

He said, another ongoing research has to do with Retinoblastoma known as childhood eye cancer which is predominant among the Fulani clan saying that this disease is either hereditary (genetic) or sporadic.

“We are collaborating with London School of hygiene and tropical diseases on this. The collaboration came about when we presented 2 papers at a conference in Spain 2 years ago” he said

On challenges being faced by Opthalmologist at the centre, Dr Hassan said ” dearth of equipment is a big issue, some time patients have to be referred abroad, not that we don’t have the man power but the equipment”

“The management are doing their best to get us some of this equipment as every year they are budgeted for. We would do better with them available” he added

VERIFIED: It is now possible to live in Nigeria and earn salary in US Dollars with premium domains, you can earn as much as $12,000 (₦18 Million).
Click here to start.